In this review
The one-time purchase model is worth comparing
SuperHealthy Rx presents compounded semaglutide starting at $79 per month and compounded tirzepatide starting at $129 per month. The current cards display monthly and three-month plan choices and advertise the same price regardless of dose, supplies and continuing provider support. These are seller offer details, not a confirmed selected-order total. [1]
The refund policy describes one-time purchases rather than automatic subscriptions, with manual reordering through the patient portal. That is a useful distinction for a reader who wants to decide before each refill. It does not remove the financial consequences of choosing a longer plan. [3]
Build a service shortlist with our provider comparisons.
Attach the payment to its actual supply
A monthly-looking figure is incomplete without the selected duration, quantity and charge collected today. The public cards do not settle a complete individualized preparation or every applicable fee. I would obtain the actual order breakdown before comparing the advertised minimum with another service’s full recurring treatment cost. [1] [2]
The policy describes longer plans and multi-month shipment schedules. Early exit from a six- or twelve-month commitment can reprice medication already shipped at the three-month rate. A manual refill model and a discounted longer commitment can coexist; one should not conceal the other in a price comparison. [3]
Separate the actual payment and supply in the cost planner.
Compounded does not mean the branded medicine was supplied
The product page labels these offers as compounded. FDA explains that compounded medicines are not FDA approved and do not receive its premarket review for safety, effectiveness or quality. It recommends compounding only when a patient’s medical needs cannot be met by an approved drug. [1] [5]
That distinction should remain visible beside any attractive price. A branded-medicine trial is not proof that a particular compounded preparation or this service will reproduce the same outcome. The clinical decision needs the actual formulation and dispensing pharmacy, rather than a broad comparison based only on an ingredient name.
For another prescribing and medication-cost arrangement, read our LifeMD review.
Payment does not guarantee the prescription
The terms describe payment for review, coordination and related platform services, with treatment and prescribing left to the provider’s judgment. The FAQ explains that payment is taken before clinical review. This means the refund rules matter before the patient knows the final prescribing decision. [2] [4]
Service availability is therapy- and state-dependent according to the public FAQ. Its pharmacy answer does not identify the pharmacy for an individual order. I would establish the clinical and dispensing parties for the selected preparation, along with the route for follow-up questions, before moving care. [4]
For a different care model, compare our Found review.
The consultation fee changes the refund question
The opened payment FAQ promises a full refund if a provider does not approve the prescription. The refund policy also excludes a $50–$100 consultation fee, including when approval is declined. Both statements are published; I would request the exact net refund rather than repeat the broader promise. [3] [4]
The policy and terms use different provider-review and pharmacy-transfer triggers for cancellation. They also describe thirty-day finalization that can restrict refunds without shipment. Do not wait for a parcel before considering whether the order has crossed a financial cutoff. [2] [3]
For another example of treatment and refund boundaries, see our FuturHealth review.
My shortlist decision
I would compare SuperHealthy Rx for its manual ordering approach after resolving the selected preparation, full payment and consultation-fee treatment. Dose-independent pricing is an offer feature, not a reason to change treatment or expect a particular outcome.
Compare a second service on the same medication category, support and paid duration. If the main attraction remains a small starting figure while the net refund is unclear, the purchase is not ready. A clear agreement is more useful than a broad promise about low cost or guaranteed results.
Keep an outcome question distinct from service pricing in our food-noise evidence review.
For separately itemized monthly and three-month plans, read our HealthiCare review.
Understanding the cost
Starting figures identify an advertised supply, not a verified complete selected-order total. Refund policy describes one-time purchases and manual reorders. Longer-plan early exit can remove the discount. Full-ineligibility-refund wording conflicts with a nonrefundable $50–$100 consultation fee; obtain the exact fee and refund before payment. Provider-review/pharmacy cutoffs and a 30-day finalization rule can limit refunds.
Build your cost estimateSources
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.